Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prenatal Exposure Delayed Effects | 83 | 2024 | 2517 | 4.720 |
Why?
|
Adiposity | 57 | 2024 | 1879 | 3.960 |
Why?
|
Fetal Blood | 47 | 2024 | 1348 | 3.100 |
Why?
|
Fluorocarbons | 25 | 2024 | 492 | 2.810 |
Why?
|
Body Mass Index | 125 | 2024 | 12952 | 2.340 |
Why?
|
Pregnancy | 227 | 2024 | 29893 | 2.250 |
Why?
|
DNA Methylation | 40 | 2024 | 4384 | 2.200 |
Why?
|
Environmental Pollutants | 26 | 2024 | 1276 | 2.050 |
Why?
|
Obesity | 73 | 2023 | 12940 | 1.730 |
Why?
|
Pregnancy Trimester, Second | 29 | 2024 | 732 | 1.540 |
Why?
|
Diabetes, Gestational | 26 | 2024 | 1250 | 1.530 |
Why?
|
Weight Gain | 33 | 2024 | 2349 | 1.520 |
Why?
|
Alkanesulfonic Acids | 16 | 2024 | 201 | 1.510 |
Why?
|
Mothers | 35 | 2023 | 2193 | 1.430 |
Why?
|
Maternal Exposure | 20 | 2024 | 1067 | 1.420 |
Why?
|
Breast Feeding | 29 | 2023 | 1356 | 1.370 |
Why?
|
Overweight | 28 | 2022 | 2418 | 1.340 |
Why?
|
Child, Preschool | 172 | 2024 | 42225 | 1.300 |
Why?
|
Child | 223 | 2024 | 80154 | 1.230 |
Why?
|
Fetal Development | 14 | 2022 | 768 | 1.220 |
Why?
|
Child Development | 28 | 2023 | 2302 | 1.150 |
Why?
|
Pregnancy Complications | 24 | 2024 | 2949 | 1.110 |
Why?
|
Body Weight | 28 | 2022 | 4618 | 1.100 |
Why?
|
Diet | 38 | 2024 | 8048 | 1.100 |
Why?
|
Asthma | 29 | 2024 | 6230 | 1.090 |
Why?
|
Child Behavior | 10 | 2022 | 848 | 1.070 |
Why?
|
Maternal Nutritional Physiological Phenomena | 12 | 2022 | 390 | 1.070 |
Why?
|
Hypertension, Pregnancy-Induced | 13 | 2024 | 518 | 1.060 |
Why?
|
Cognition | 27 | 2023 | 6988 | 1.040 |
Why?
|
Female | 398 | 2024 | 392552 | 1.040 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 10 | 2021 | 160 | 1.020 |
Why?
|
Feeding Behavior | 22 | 2020 | 3183 | 1.010 |
Why?
|
Birth Weight | 34 | 2024 | 2104 | 1.000 |
Why?
|
Massachusetts | 81 | 2024 | 8837 | 1.000 |
Why?
|
Cesarean Section | 6 | 2021 | 1399 | 0.990 |
Why?
|
Pregnancy Trimester, First | 19 | 2024 | 908 | 0.970 |
Why?
|
Postpartum Period | 21 | 2023 | 1178 | 0.960 |
Why?
|
Infant, Newborn | 103 | 2023 | 26200 | 0.960 |
Why?
|
Body Height | 13 | 2021 | 1566 | 0.950 |
Why?
|
Cohort Studies | 115 | 2024 | 41496 | 0.940 |
Why?
|
Blood Pressure | 31 | 2024 | 8479 | 0.930 |
Why?
|
Prospective Studies | 126 | 2024 | 54437 | 0.890 |
Why?
|
Infant | 116 | 2023 | 36170 | 0.860 |
Why?
|
Mercury | 6 | 2023 | 289 | 0.860 |
Why?
|
Humans | 437 | 2024 | 761222 | 0.780 |
Why?
|
Leptin | 13 | 2024 | 1595 | 0.770 |
Why?
|
Anthropometry | 13 | 2021 | 1338 | 0.740 |
Why?
|
Epigenesis, Genetic | 24 | 2024 | 3788 | 0.730 |
Why?
|
Metals | 6 | 2024 | 711 | 0.720 |
Why?
|
Premature Birth | 11 | 2023 | 1784 | 0.720 |
Why?
|
Acetaminophen | 3 | 2020 | 555 | 0.710 |
Why?
|
Caprylates | 9 | 2024 | 115 | 0.710 |
Why?
|
Ibuprofen | 2 | 2019 | 229 | 0.710 |
Why?
|
Male | 264 | 2024 | 360703 | 0.700 |
Why?
|
Television | 12 | 2018 | 407 | 0.700 |
Why?
|
Glucose Intolerance | 10 | 2020 | 575 | 0.690 |
Why?
|
Respiratory Sounds | 11 | 2021 | 702 | 0.690 |
Why?
|
Adolescent | 121 | 2024 | 88300 | 0.680 |
Why?
|
Sleep Deprivation | 7 | 2017 | 847 | 0.670 |
Why?
|
Air Pollution | 12 | 2023 | 2351 | 0.670 |
Why?
|
Infertility | 5 | 2024 | 654 | 0.660 |
Why?
|
Executive Function | 11 | 2022 | 1388 | 0.650 |
Why?
|
Waist Circumference | 15 | 2024 | 933 | 0.650 |
Why?
|
Infant Nutritional Physiological Phenomena | 5 | 2023 | 351 | 0.650 |
Why?
|
Obesity, Abdominal | 4 | 2021 | 373 | 0.640 |
Why?
|
Longitudinal Studies | 50 | 2024 | 14610 | 0.620 |
Why?
|
Environmental Exposure | 18 | 2024 | 4479 | 0.620 |
Why?
|
Anti-Bacterial Agents | 19 | 2021 | 7407 | 0.610 |
Why?
|
Adiponectin | 11 | 2024 | 1107 | 0.610 |
Why?
|
Blood Glucose | 16 | 2024 | 6392 | 0.600 |
Why?
|
Adult | 183 | 2024 | 221120 | 0.600 |
Why?
|
Carrier State | 11 | 2013 | 522 | 0.570 |
Why?
|
Residence Characteristics | 14 | 2024 | 2092 | 0.570 |
Why?
|
Pregnancy Outcome | 14 | 2022 | 2923 | 0.570 |
Why?
|
Food Hypersensitivity | 6 | 2022 | 726 | 0.570 |
Why?
|
Health Status Disparities | 6 | 2016 | 1847 | 0.560 |
Why?
|
Linear Models | 36 | 2023 | 5869 | 0.540 |
Why?
|
Seafood | 5 | 2018 | 393 | 0.530 |
Why?
|
Hair | 5 | 2024 | 498 | 0.520 |
Why?
|
Hormones | 2 | 2017 | 868 | 0.520 |
Why?
|
Pregnancy Trimesters | 7 | 2020 | 197 | 0.510 |
Why?
|
Absorptiometry, Photon | 11 | 2024 | 1738 | 0.500 |
Why?
|
Body Composition | 11 | 2023 | 2427 | 0.500 |
Why?
|
Parturition | 5 | 2023 | 447 | 0.490 |
Why?
|
Arsenic | 3 | 2024 | 361 | 0.480 |
Why?
|
Parenting | 5 | 2020 | 701 | 0.480 |
Why?
|
Environment Design | 4 | 2021 | 173 | 0.480 |
Why?
|
Insulin Resistance | 9 | 2024 | 3952 | 0.470 |
Why?
|
Pre-Eclampsia | 7 | 2024 | 1233 | 0.470 |
Why?
|
Child Behavior Disorders | 1 | 2019 | 804 | 0.470 |
Why?
|
Sleep | 17 | 2023 | 4759 | 0.470 |
Why?
|
Socioeconomic Factors | 29 | 2023 | 7804 | 0.470 |
Why?
|
Beverages | 7 | 2018 | 821 | 0.470 |
Why?
|
Pneumococcal Vaccines | 8 | 2013 | 397 | 0.460 |
Why?
|
Gestational Age | 21 | 2023 | 3580 | 0.460 |
Why?
|
Child Nutritional Physiological Phenomena | 8 | 2016 | 292 | 0.460 |
Why?
|
Insulin-Like Growth Factor II | 4 | 2021 | 267 | 0.460 |
Why?
|
Risk Factors | 80 | 2024 | 74241 | 0.450 |
Why?
|
Corticotropin-Releasing Hormone | 3 | 2018 | 359 | 0.450 |
Why?
|
Selenium | 3 | 2022 | 416 | 0.440 |
Why?
|
Air Pollutants | 11 | 2024 | 2889 | 0.440 |
Why?
|
Fast Foods | 5 | 2019 | 210 | 0.440 |
Why?
|
Health Behavior | 11 | 2022 | 2641 | 0.440 |
Why?
|
Adipokines | 4 | 2024 | 307 | 0.430 |
Why?
|
Pneumococcal Infections | 8 | 2013 | 501 | 0.430 |
Why?
|
Micronutrients | 4 | 2023 | 381 | 0.420 |
Why?
|
Menopause | 5 | 2024 | 1646 | 0.420 |
Why?
|
Lead | 6 | 2023 | 879 | 0.420 |
Why?
|
Parents | 14 | 2020 | 3564 | 0.410 |
Why?
|
Pregnant Women | 4 | 2020 | 568 | 0.410 |
Why?
|
Growth Charts | 2 | 2017 | 60 | 0.410 |
Why?
|
Vitamin D | 9 | 2024 | 3301 | 0.410 |
Why?
|
Maternal Behavior | 5 | 2019 | 307 | 0.400 |
Why?
|
CpG Islands | 10 | 2022 | 1190 | 0.400 |
Why?
|
Lutein | 3 | 2022 | 123 | 0.390 |
Why?
|
Hydrocortisone | 5 | 2024 | 1818 | 0.390 |
Why?
|
Growth | 4 | 2017 | 366 | 0.380 |
Why?
|
Hypersensitivity, Immediate | 3 | 2019 | 348 | 0.380 |
Why?
|
Metabolomics | 5 | 2024 | 1658 | 0.380 |
Why?
|
Thyroxine | 3 | 2020 | 665 | 0.380 |
Why?
|
Maternal-Fetal Exchange | 7 | 2020 | 461 | 0.370 |
Why?
|
Primary Health Care | 6 | 2016 | 4679 | 0.370 |
Why?
|
Milk | 5 | 2022 | 440 | 0.370 |
Why?
|
Anti-Mullerian Hormone | 2 | 2024 | 407 | 0.370 |
Why?
|
Alanine Transaminase | 3 | 2018 | 602 | 0.370 |
Why?
|
Fatty Acids, Omega-3 | 7 | 2019 | 1390 | 0.360 |
Why?
|
Decanoic Acids | 3 | 2021 | 68 | 0.360 |
Why?
|
Depression, Postpartum | 3 | 2023 | 349 | 0.360 |
Why?
|
Cross-Sectional Studies | 42 | 2024 | 26072 | 0.350 |
Why?
|
Lipids | 9 | 2024 | 3331 | 0.350 |
Why?
|
Republic of Belarus | 5 | 2021 | 38 | 0.350 |
Why?
|
Multivariate Analysis | 34 | 2021 | 12052 | 0.340 |
Why?
|
Metabolic Diseases | 3 | 2021 | 680 | 0.330 |
Why?
|
Thinness | 4 | 2020 | 481 | 0.330 |
Why?
|
Restaurants | 3 | 2019 | 231 | 0.330 |
Why?
|
Intelligence | 4 | 2022 | 922 | 0.320 |
Why?
|
Age Factors | 21 | 2024 | 18384 | 0.320 |
Why?
|
Smoking | 12 | 2020 | 9055 | 0.310 |
Why?
|
Dietary Sucrose | 4 | 2018 | 243 | 0.310 |
Why?
|
Pregnancy Trimester, Third | 7 | 2024 | 583 | 0.300 |
Why?
|
Streptococcus pneumoniae | 7 | 2012 | 730 | 0.300 |
Why?
|
Skinfold Thickness | 7 | 2017 | 163 | 0.300 |
Why?
|
Dermatitis, Atopic | 4 | 2018 | 731 | 0.300 |
Why?
|
Immunoglobulin E | 7 | 2022 | 1505 | 0.290 |
Why?
|
Menarche | 2 | 2021 | 532 | 0.290 |
Why?
|
Sexual Maturation | 2 | 2019 | 261 | 0.290 |
Why?
|
Methylmercury Compounds | 2 | 2021 | 103 | 0.290 |
Why?
|
United States | 49 | 2024 | 72341 | 0.280 |
Why?
|
Cardiovascular Diseases | 12 | 2022 | 15521 | 0.280 |
Why?
|
Family | 6 | 2018 | 3192 | 0.280 |
Why?
|
Inflammation | 12 | 2023 | 10759 | 0.280 |
Why?
|
Boston | 20 | 2024 | 9327 | 0.280 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 3 | 2017 | 415 | 0.280 |
Why?
|
Nasal Mucosa | 2 | 2021 | 413 | 0.280 |
Why?
|
Respiratory Tract Infections | 6 | 2018 | 1009 | 0.280 |
Why?
|
Bayes Theorem | 11 | 2023 | 2329 | 0.270 |
Why?
|
Genome-Wide Association Study | 11 | 2024 | 12676 | 0.270 |
Why?
|
Logistic Models | 32 | 2021 | 13249 | 0.270 |
Why?
|
Insulin-Like Growth Factor I | 5 | 2017 | 1933 | 0.270 |
Why?
|
Metabolism | 2 | 2018 | 193 | 0.260 |
Why?
|
Odds Ratio | 22 | 2022 | 9652 | 0.260 |
Why?
|
Analgesics, Non-Narcotic | 3 | 2020 | 370 | 0.260 |
Why?
|
Parity | 8 | 2023 | 929 | 0.260 |
Why?
|
Nitric Oxide | 4 | 2024 | 2137 | 0.260 |
Why?
|
Dietary Fats | 6 | 2021 | 1994 | 0.260 |
Why?
|
Health Promotion | 7 | 2018 | 2205 | 0.260 |
Why?
|
Depression | 10 | 2023 | 8132 | 0.250 |
Why?
|
Vitamin D Deficiency | 4 | 2024 | 1388 | 0.250 |
Why?
|
Delivery, Obstetric | 3 | 2021 | 941 | 0.250 |
Why?
|
World Health Organization | 1 | 2011 | 1321 | 0.250 |
Why?
|
Leisure Activities | 4 | 2015 | 308 | 0.250 |
Why?
|
Adolescent Development | 2 | 2019 | 282 | 0.250 |
Why?
|
Glucose Tolerance Test | 10 | 2020 | 1178 | 0.250 |
Why?
|
Particulate Matter | 7 | 2021 | 2597 | 0.250 |
Why?
|
Hypersensitivity | 4 | 2019 | 1167 | 0.250 |
Why?
|
Staphylococcal Infections | 5 | 2016 | 1401 | 0.250 |
Why?
|
Follow-Up Studies | 34 | 2019 | 39127 | 0.250 |
Why?
|
Bone Density | 4 | 2024 | 3546 | 0.240 |
Why?
|
Thyrotropin | 2 | 2019 | 833 | 0.240 |
Why?
|
Energy Intake | 7 | 2018 | 2133 | 0.240 |
Why?
|
Hyperglycemia | 4 | 2022 | 1375 | 0.240 |
Why?
|
Maternal Age | 9 | 2019 | 809 | 0.240 |
Why?
|
Life Style | 8 | 2024 | 3907 | 0.240 |
Why?
|
Eggs | 2 | 2022 | 182 | 0.240 |
Why?
|
Vitamins | 5 | 2024 | 1634 | 0.240 |
Why?
|
Folic Acid | 7 | 2023 | 1323 | 0.230 |
Why?
|
Lead Poisoning | 2 | 2019 | 323 | 0.230 |
Why?
|
Young Adult | 38 | 2024 | 59222 | 0.230 |
Why?
|
Mass Screening | 4 | 2014 | 5426 | 0.230 |
Why?
|
Metals, Heavy | 2 | 2024 | 148 | 0.230 |
Why?
|
Hypertension | 10 | 2024 | 8536 | 0.230 |
Why?
|
Food Labeling | 2 | 2019 | 179 | 0.230 |
Why?
|
Trace Elements | 2 | 2022 | 193 | 0.230 |
Why?
|
Pollen | 1 | 2024 | 81 | 0.220 |
Why?
|
Adolescent Behavior | 5 | 2016 | 1188 | 0.220 |
Why?
|
Dietary Proteins | 4 | 2017 | 951 | 0.220 |
Why?
|
Risk Assessment | 19 | 2024 | 24022 | 0.220 |
Why?
|
Diet, Mediterranean | 3 | 2022 | 738 | 0.220 |
Why?
|
Antihypertensive Agents | 2 | 2024 | 2019 | 0.220 |
Why?
|
Lactation | 4 | 2023 | 397 | 0.220 |
Why?
|
Guideline Adherence | 3 | 2024 | 2220 | 0.220 |
Why?
|
Sweetening Agents | 3 | 2021 | 290 | 0.220 |
Why?
|
Humidity | 1 | 2024 | 205 | 0.210 |
Why?
|
Epigenomics | 5 | 2021 | 944 | 0.210 |
Why?
|
Infant, Premature | 4 | 2020 | 2106 | 0.210 |
Why?
|
Birth Order | 1 | 2023 | 95 | 0.210 |
Why?
|
Fetal Growth Retardation | 3 | 2016 | 580 | 0.210 |
Why?
|
Dietary Supplements | 9 | 2021 | 3410 | 0.210 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 4 | 2016 | 696 | 0.200 |
Why?
|
Egg Hypersensitivity | 1 | 2022 | 47 | 0.200 |
Why?
|
Pandemics | 1 | 2022 | 8663 | 0.200 |
Why?
|
Environment | 2 | 2021 | 1122 | 0.200 |
Why?
|
Food Preferences | 4 | 2020 | 398 | 0.200 |
Why?
|
Seasons | 4 | 2024 | 1518 | 0.200 |
Why?
|
Anxiety | 6 | 2023 | 4569 | 0.200 |
Why?
|
Nutrition Assessment | 2 | 2024 | 727 | 0.190 |
Why?
|
gamma-Tocopherol | 2 | 2020 | 30 | 0.190 |
Why?
|
Nutrition Surveys | 5 | 2021 | 1723 | 0.190 |
Why?
|
Exercise | 11 | 2019 | 5874 | 0.190 |
Why?
|
Milk Hypersensitivity | 1 | 2022 | 82 | 0.190 |
Why?
|
Vehicle Emissions | 5 | 2022 | 655 | 0.190 |
Why?
|
Menopause, Premature | 1 | 2022 | 124 | 0.190 |
Why?
|
Manganese | 2 | 2021 | 391 | 0.180 |
Why?
|
Eating | 4 | 2021 | 1535 | 0.180 |
Why?
|
Choline | 4 | 2022 | 515 | 0.180 |
Why?
|
Allergens | 5 | 2024 | 1433 | 0.180 |
Why?
|
Weight Loss | 5 | 2020 | 2680 | 0.180 |
Why?
|
Health Status | 4 | 2022 | 4077 | 0.180 |
Why?
|
Electronic Health Records | 8 | 2024 | 4822 | 0.170 |
Why?
|
Nickel | 1 | 2020 | 126 | 0.170 |
Why?
|
Food Contamination | 1 | 2021 | 191 | 0.170 |
Why?
|
Puberty | 2 | 2021 | 501 | 0.170 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2020 | 91 | 0.170 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2024 | 376 | 0.170 |
Why?
|
alpha-Tocopherol | 1 | 2020 | 126 | 0.170 |
Why?
|
Antidepressive Agents | 2 | 2024 | 2893 | 0.170 |
Why?
|
Birth Certificates | 2 | 2016 | 71 | 0.170 |
Why?
|
Temperature | 2 | 2024 | 2219 | 0.170 |
Why?
|
Genomic Imprinting | 1 | 2021 | 323 | 0.170 |
Why?
|
Prevalence | 18 | 2019 | 15721 | 0.170 |
Why?
|
Social Environment | 2 | 2015 | 1022 | 0.160 |
Why?
|
Abdominal Fat | 1 | 2021 | 221 | 0.160 |
Why?
|
Hand Strength | 1 | 2022 | 456 | 0.160 |
Why?
|
Cross Infection | 3 | 2016 | 1422 | 0.160 |
Why?
|
Social Support | 3 | 2019 | 2175 | 0.160 |
Why?
|
Fructosamine | 1 | 2018 | 14 | 0.160 |
Why?
|
Thyroid Function Tests | 1 | 2020 | 288 | 0.160 |
Why?
|
Environmental Illness | 1 | 2019 | 34 | 0.160 |
Why?
|
Paternal Exposure | 1 | 2019 | 96 | 0.160 |
Why?
|
Soot | 2 | 2018 | 221 | 0.160 |
Why?
|
Sex Factors | 11 | 2022 | 10553 | 0.160 |
Why?
|
Educational Status | 7 | 2022 | 2510 | 0.160 |
Why?
|
Drug Prescriptions | 4 | 2024 | 1668 | 0.160 |
Why?
|
Education, Nonprofessional | 2 | 2015 | 31 | 0.160 |
Why?
|
Crown-Rump Length | 1 | 2018 | 31 | 0.160 |
Why?
|
Social Class | 4 | 2019 | 1993 | 0.160 |
Why?
|
Satiation | 1 | 2019 | 82 | 0.160 |
Why?
|
Proteobacteria | 1 | 2018 | 46 | 0.160 |
Why?
|
Fatty Acids, Omega-6 | 2 | 2011 | 225 | 0.160 |
Why?
|
Appetite Regulation | 1 | 2019 | 84 | 0.150 |
Why?
|
Diet Surveys | 4 | 2024 | 1161 | 0.150 |
Why?
|
Diagnostic Errors | 1 | 2005 | 1265 | 0.150 |
Why?
|
Regression Analysis | 11 | 2020 | 6345 | 0.150 |
Why?
|
Actigraphy | 2 | 2019 | 522 | 0.150 |
Why?
|
Heart | 2 | 2024 | 4431 | 0.150 |
Why?
|
Enterococcus | 2 | 2011 | 159 | 0.150 |
Why?
|
Food Supply | 2 | 2015 | 539 | 0.150 |
Why?
|
Prescriptions | 1 | 2020 | 386 | 0.150 |
Why?
|
Behavior | 1 | 2021 | 540 | 0.150 |
Why?
|
Phthalic Acids | 1 | 2023 | 478 | 0.150 |
Why?
|
Health Maintenance Organizations | 3 | 2006 | 658 | 0.150 |
Why?
|
Metabolome | 3 | 2024 | 989 | 0.150 |
Why?
|
Fathers | 2 | 2021 | 375 | 0.150 |
Why?
|
Drug Utilization | 5 | 2012 | 1188 | 0.150 |
Why?
|
Time Factors | 26 | 2020 | 39957 | 0.150 |
Why?
|
Pesticide Residues | 1 | 2018 | 95 | 0.140 |
Why?
|
Cluster Analysis | 9 | 2018 | 2706 | 0.140 |
Why?
|
Bulimia | 2 | 2010 | 400 | 0.140 |
Why?
|
Computer Security | 1 | 2019 | 260 | 0.140 |
Why?
|
Europe | 6 | 2020 | 3423 | 0.140 |
Why?
|
Hypotension | 1 | 2023 | 879 | 0.140 |
Why?
|
Fruit | 3 | 2018 | 1158 | 0.140 |
Why?
|
Privacy | 1 | 2019 | 233 | 0.140 |
Why?
|
Vegetables | 3 | 2018 | 1192 | 0.140 |
Why?
|
Sarcopenia | 1 | 2022 | 370 | 0.140 |
Why?
|
Glucocorticoids | 2 | 2023 | 2159 | 0.140 |
Why?
|
DNA-Binding Proteins | 3 | 2019 | 9567 | 0.140 |
Why?
|
Vitamin E | 2 | 2018 | 872 | 0.140 |
Why?
|
Ultrasonography, Prenatal | 3 | 2022 | 1757 | 0.140 |
Why?
|
Paternity | 1 | 2016 | 14 | 0.140 |
Why?
|
Nasopharynx | 6 | 2012 | 400 | 0.140 |
Why?
|
C-Reactive Protein | 8 | 2018 | 3821 | 0.140 |
Why?
|
Breath Tests | 3 | 2024 | 299 | 0.140 |
Why?
|
Religion | 1 | 2019 | 376 | 0.130 |
Why?
|
Lymphocytes | 1 | 2024 | 2603 | 0.130 |
Why?
|
Glycemic Index | 1 | 2018 | 396 | 0.130 |
Why?
|
Weather | 1 | 2017 | 231 | 0.130 |
Why?
|
Vision, Low | 1 | 2018 | 163 | 0.130 |
Why?
|
Vaccines, Conjugate | 4 | 2013 | 328 | 0.130 |
Why?
|
Psychomotor Disorders | 1 | 2017 | 149 | 0.130 |
Why?
|
Insulin | 4 | 2021 | 6588 | 0.130 |
Why?
|
Siblings | 2 | 2019 | 824 | 0.130 |
Why?
|
Patient Compliance | 2 | 2017 | 2688 | 0.130 |
Why?
|
Thyroid Diseases | 1 | 2019 | 386 | 0.130 |
Why?
|
Body Fat Distribution | 2 | 2014 | 245 | 0.130 |
Why?
|
Fishes | 2 | 2016 | 600 | 0.130 |
Why?
|
Glomerular Filtration Rate | 1 | 2024 | 2182 | 0.130 |
Why?
|
Choice Behavior | 2 | 2019 | 825 | 0.130 |
Why?
|
Parent-Child Relations | 3 | 2016 | 762 | 0.130 |
Why?
|
Erythrocytes | 3 | 2021 | 2413 | 0.130 |
Why?
|
North America | 4 | 2020 | 1284 | 0.130 |
Why?
|
Food | 3 | 2017 | 768 | 0.130 |
Why?
|
Snoring | 1 | 2017 | 209 | 0.130 |
Why?
|
Peptide Hormones | 1 | 2016 | 132 | 0.130 |
Why?
|
Surgery, Plastic | 1 | 2022 | 640 | 0.120 |
Why?
|
Confidentiality | 1 | 2019 | 605 | 0.120 |
Why?
|
Intra-Abdominal Fat | 1 | 2020 | 612 | 0.120 |
Why?
|
Infant Formula | 3 | 2022 | 194 | 0.120 |
Why?
|
Eosinophilic Esophagitis | 1 | 2018 | 199 | 0.120 |
Why?
|
Sports | 1 | 2001 | 705 | 0.120 |
Why?
|
Stochastic Processes | 1 | 2016 | 355 | 0.120 |
Why?
|
Child Abuse | 1 | 2023 | 1076 | 0.120 |
Why?
|
Eicosapentaenoic Acid | 1 | 2018 | 561 | 0.120 |
Why?
|
Medical Record Linkage | 1 | 2016 | 286 | 0.120 |
Why?
|
Directive Counseling | 1 | 2016 | 170 | 0.120 |
Why?
|
Maternal Welfare | 1 | 2014 | 112 | 0.110 |
Why?
|
Meningococcal Vaccines | 2 | 2005 | 94 | 0.110 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2013 | 4014 | 0.110 |
Why?
|
Triticum | 1 | 2014 | 90 | 0.110 |
Why?
|
Calcium, Dietary | 2 | 2008 | 529 | 0.110 |
Why?
|
Body Image | 3 | 2010 | 639 | 0.110 |
Why?
|
Psychomotor Performance | 3 | 2011 | 1880 | 0.110 |
Why?
|
Body Weights and Measures | 1 | 2014 | 208 | 0.110 |
Why?
|
Drinking | 1 | 2014 | 198 | 0.110 |
Why?
|
Nedocromil | 1 | 2013 | 45 | 0.110 |
Why?
|
Infant Food | 2 | 2011 | 139 | 0.110 |
Why?
|
Diabetes Mellitus | 3 | 2014 | 5842 | 0.110 |
Why?
|
Practice Guidelines as Topic | 3 | 2024 | 7400 | 0.110 |
Why?
|
Vancomycin Resistance | 2 | 2011 | 125 | 0.110 |
Why?
|
Spouses | 1 | 2016 | 284 | 0.110 |
Why?
|
Perinatal Care | 1 | 2016 | 244 | 0.110 |
Why?
|
Obsessive Behavior | 1 | 2013 | 51 | 0.110 |
Why?
|
Statistics as Topic | 3 | 2015 | 2359 | 0.110 |
Why?
|
Methicillin Resistance | 2 | 2011 | 198 | 0.110 |
Why?
|
Cytokines | 2 | 2024 | 7386 | 0.110 |
Why?
|
Walking | 3 | 2015 | 1194 | 0.100 |
Why?
|
Colitis, Ulcerative | 3 | 2011 | 1920 | 0.100 |
Why?
|
Attitude to Health | 3 | 2014 | 2026 | 0.100 |
Why?
|
Nutritional Status | 5 | 2018 | 1597 | 0.100 |
Why?
|
Crohn Disease | 3 | 2011 | 2278 | 0.100 |
Why?
|
Budesonide | 1 | 2013 | 158 | 0.100 |
Why?
|
Health Education | 3 | 2008 | 1049 | 0.100 |
Why?
|
Tobacco Smoke Pollution | 1 | 2018 | 821 | 0.100 |
Why?
|
Lung | 3 | 2022 | 9979 | 0.100 |
Why?
|
Urbanization | 1 | 2012 | 100 | 0.100 |
Why?
|
Docosahexaenoic Acids | 1 | 2018 | 906 | 0.100 |
Why?
|
Child Day Care Centers | 2 | 2009 | 122 | 0.100 |
Why?
|
Fatty Acids | 3 | 2016 | 1807 | 0.100 |
Why?
|
Forced Expiratory Volume | 4 | 2019 | 1813 | 0.100 |
Why?
|
Motor Activity | 2 | 2015 | 2712 | 0.090 |
Why?
|
Self Report | 4 | 2024 | 3727 | 0.090 |
Why?
|
Staphylococcus aureus | 2 | 2011 | 1450 | 0.090 |
Why?
|
Information Dissemination | 1 | 2019 | 1129 | 0.090 |
Why?
|
Feeding Methods | 1 | 2011 | 35 | 0.090 |
Why?
|
Diagnostic Tests, Routine | 2 | 2006 | 788 | 0.090 |
Why?
|
Pneumonia, Pneumococcal | 1 | 2012 | 130 | 0.090 |
Why?
|
Risk | 5 | 2018 | 9616 | 0.090 |
Why?
|
Models, Genetic | 1 | 2021 | 3430 | 0.090 |
Why?
|
Weaning | 1 | 2011 | 103 | 0.090 |
Why?
|
Autoantibodies | 1 | 2019 | 2119 | 0.090 |
Why?
|
Achievement | 1 | 2012 | 288 | 0.090 |
Why?
|
Developmental Disabilities | 1 | 2019 | 1510 | 0.090 |
Why?
|
Exhalation | 2 | 2023 | 182 | 0.090 |
Why?
|
Androgens | 1 | 2018 | 1283 | 0.090 |
Why?
|
Probability | 4 | 2021 | 2478 | 0.090 |
Why?
|
Information Seeking Behavior | 1 | 2011 | 116 | 0.090 |
Why?
|
Incidence | 12 | 2019 | 21366 | 0.090 |
Why?
|
Population Surveillance | 1 | 2021 | 2598 | 0.090 |
Why?
|
Trans Fatty Acids | 1 | 2011 | 155 | 0.090 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2731 | 0.090 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2012 | 330 | 0.090 |
Why?
|
Interleukin-6 | 4 | 2014 | 3210 | 0.080 |
Why?
|
Fimbriae Proteins | 1 | 2010 | 132 | 0.080 |
Why?
|
Glucose | 4 | 2022 | 4342 | 0.080 |
Why?
|
Mother-Child Relations | 2 | 2010 | 495 | 0.080 |
Why?
|
Chronic Disease | 2 | 2022 | 9319 | 0.080 |
Why?
|
Bronchodilator Agents | 1 | 2013 | 512 | 0.080 |
Why?
|
Reproducibility of Results | 6 | 2024 | 20118 | 0.080 |
Why?
|
Aging | 3 | 2024 | 8702 | 0.080 |
Why?
|
Communicable Disease Control | 1 | 2016 | 846 | 0.080 |
Why?
|
Infant, Small for Gestational Age | 1 | 2012 | 463 | 0.080 |
Why?
|
Patient Isolation | 1 | 2010 | 100 | 0.080 |
Why?
|
Body Size | 3 | 2022 | 463 | 0.080 |
Why?
|
Immunoglobulin G | 2 | 2018 | 4537 | 0.080 |
Why?
|
Drug Resistance, Bacterial | 3 | 2012 | 1048 | 0.080 |
Why?
|
Motor Skills | 1 | 2012 | 521 | 0.080 |
Why?
|
Sentinel Surveillance | 2 | 2011 | 291 | 0.080 |
Why?
|
Menstrual Cycle | 2 | 2022 | 539 | 0.080 |
Why?
|
Sulfonic Acids | 2 | 2021 | 102 | 0.080 |
Why?
|
Cell Proliferation | 1 | 2024 | 10423 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 2254 | 0.080 |
Why?
|
Child Care | 1 | 2009 | 124 | 0.080 |
Why?
|
Visual Acuity | 1 | 2018 | 2676 | 0.080 |
Why?
|
Oxidative Stress | 1 | 2019 | 3114 | 0.080 |
Why?
|
Betaine | 3 | 2013 | 90 | 0.070 |
Why?
|
Bulimia Nervosa | 1 | 2010 | 205 | 0.070 |
Why?
|
Otitis Media | 2 | 2012 | 286 | 0.070 |
Why?
|
Intelligence Tests | 2 | 2019 | 503 | 0.070 |
Why?
|
Language Development | 1 | 2009 | 183 | 0.070 |
Why?
|
Antioxidants | 2 | 2006 | 1667 | 0.070 |
Why?
|
Middle Aged | 20 | 2024 | 220858 | 0.070 |
Why?
|
Hemodynamics | 1 | 2018 | 4165 | 0.070 |
Why?
|
Computer Simulation | 1 | 2021 | 6224 | 0.070 |
Why?
|
Confidence Intervals | 5 | 2017 | 2928 | 0.070 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 5773 | 0.070 |
Why?
|
Hypercholesterolemia | 1 | 2014 | 1141 | 0.070 |
Why?
|
Health Care Costs | 2 | 2012 | 3239 | 0.070 |
Why?
|
Iron, Dietary | 1 | 2008 | 148 | 0.070 |
Why?
|
Pregnancy in Adolescence | 1 | 2008 | 163 | 0.070 |
Why?
|
Disease Transmission, Infectious | 2 | 2010 | 561 | 0.070 |
Why?
|
Health Services | 1 | 2012 | 750 | 0.070 |
Why?
|
Acid-Base Equilibrium | 1 | 2007 | 181 | 0.070 |
Why?
|
Methicillin | 1 | 2006 | 62 | 0.070 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2019 | 2150 | 0.070 |
Why?
|
Patient Education as Topic | 3 | 2008 | 2317 | 0.070 |
Why?
|
Infant, Low Birth Weight | 3 | 2016 | 869 | 0.070 |
Why?
|
Cattle | 2 | 2022 | 3818 | 0.070 |
Why?
|
Pediatrics | 5 | 2015 | 3590 | 0.070 |
Why?
|
Carbon | 2 | 2024 | 665 | 0.070 |
Why?
|
Salaries and Fringe Benefits | 1 | 2009 | 256 | 0.070 |
Why?
|
Mexico | 2 | 2022 | 757 | 0.070 |
Why?
|
Income | 1 | 2015 | 1869 | 0.070 |
Why?
|
Diet, Reducing | 1 | 2010 | 485 | 0.070 |
Why?
|
Neuropsychological Tests | 4 | 2023 | 7046 | 0.070 |
Why?
|
Motivation | 2 | 2013 | 2002 | 0.060 |
Why?
|
Systole | 4 | 2014 | 936 | 0.060 |
Why?
|
Epidemiologic Methods | 1 | 2010 | 1336 | 0.060 |
Why?
|
Telomere | 2 | 2022 | 939 | 0.060 |
Why?
|
Stress, Psychological | 3 | 2023 | 4487 | 0.060 |
Why?
|
Vital Capacity | 2 | 2019 | 970 | 0.060 |
Why?
|
Electric Impedance | 2 | 2024 | 756 | 0.060 |
Why?
|
Dietary Carbohydrates | 3 | 2016 | 891 | 0.060 |
Why?
|
Preconception Care | 1 | 2006 | 141 | 0.060 |
Why?
|
Sex Distribution | 3 | 2018 | 2277 | 0.060 |
Why?
|
Australia | 2 | 2019 | 1246 | 0.060 |
Why?
|
Vitamin B 12 | 3 | 2013 | 524 | 0.060 |
Why?
|
Prenatal Care | 3 | 2017 | 1141 | 0.060 |
Why?
|
Models, Theoretical | 2 | 2014 | 3571 | 0.060 |
Why?
|
Databases, Factual | 5 | 2019 | 7965 | 0.060 |
Why?
|
Drug Resistance, Microbial | 1 | 2008 | 826 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 4027 | 0.060 |
Why?
|
Netherlands | 2 | 2021 | 2222 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2270 | 0.060 |
Why?
|
Serotyping | 3 | 2012 | 325 | 0.060 |
Why?
|
Health Resources | 1 | 2011 | 934 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 1 | 2016 | 4513 | 0.060 |
Why?
|
Intensive Care Units | 4 | 2016 | 3744 | 0.060 |
Why?
|
Mitogens | 1 | 2024 | 229 | 0.060 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 3201 | 0.060 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2017 | 1874 | 0.060 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2006 | 342 | 0.060 |
Why?
|
Family Characteristics | 2 | 2023 | 992 | 0.060 |
Why?
|
Eczema | 1 | 2006 | 246 | 0.060 |
Why?
|
Alkanesulfonates | 1 | 2023 | 15 | 0.060 |
Why?
|
Environmental Monitoring | 3 | 2015 | 1460 | 0.060 |
Why?
|
Otitis | 1 | 2003 | 21 | 0.060 |
Why?
|
New England | 2 | 2019 | 1052 | 0.060 |
Why?
|
Drug Resistance, Multiple, Bacterial | 2 | 2009 | 585 | 0.050 |
Why?
|
Vancomycin | 1 | 2006 | 503 | 0.050 |
Why?
|
Case Management | 1 | 2005 | 272 | 0.050 |
Why?
|
Rhinitis, Allergic, Seasonal | 1 | 2024 | 105 | 0.050 |
Why?
|
Respiratory Function Tests | 2 | 2020 | 1685 | 0.050 |
Why?
|
Particle Size | 2 | 2019 | 1649 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 11855 | 0.050 |
Why?
|
Spirometry | 2 | 2018 | 928 | 0.050 |
Why?
|
Cardiovascular System | 1 | 2010 | 836 | 0.050 |
Why?
|
Clinical Clerkship | 1 | 2009 | 564 | 0.050 |
Why?
|
Hospitals | 1 | 2016 | 3881 | 0.050 |
Why?
|
Age Distribution | 3 | 2013 | 2871 | 0.050 |
Why?
|
Trees | 1 | 2022 | 57 | 0.050 |
Why?
|
Bupropion | 1 | 2024 | 304 | 0.050 |
Why?
|
Thyroid Gland | 2 | 2020 | 1169 | 0.050 |
Why?
|
Schools, Medical | 1 | 2009 | 878 | 0.050 |
Why?
|
Adipose Tissue | 3 | 2019 | 3313 | 0.050 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2019 | 6011 | 0.050 |
Why?
|
Case-Control Studies | 5 | 2019 | 22174 | 0.050 |
Why?
|
Vocabulary | 1 | 2022 | 166 | 0.050 |
Why?
|
Reward | 1 | 2009 | 968 | 0.050 |
Why?
|
Retrospective Studies | 13 | 2022 | 80675 | 0.050 |
Why?
|
Milk Proteins | 1 | 2022 | 162 | 0.050 |
Why?
|
Hyperphagia | 1 | 2022 | 139 | 0.050 |
Why?
|
Carotenoids | 1 | 2004 | 621 | 0.050 |
Why?
|
Models, Structural | 1 | 2021 | 338 | 0.050 |
Why?
|
Mass Media | 1 | 2004 | 303 | 0.050 |
Why?
|
Cadmium | 1 | 2022 | 215 | 0.050 |
Why?
|
Citalopram | 1 | 2024 | 402 | 0.050 |
Why?
|
Patient Participation | 1 | 2010 | 1445 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2011 | 15308 | 0.050 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2021 | 139 | 0.050 |
Why?
|
Mediator Complex | 1 | 2021 | 106 | 0.050 |
Why?
|
Models, Statistical | 2 | 2014 | 5081 | 0.050 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2022 | 12159 | 0.050 |
Why?
|
Teaching | 1 | 2009 | 1171 | 0.050 |
Why?
|
Cytosine | 1 | 2022 | 212 | 0.050 |
Why?
|
Phenotype | 4 | 2019 | 16575 | 0.050 |
Why?
|
Guanine | 1 | 2022 | 278 | 0.040 |
Why?
|
Calcium Channel Blockers | 1 | 2024 | 691 | 0.040 |
Why?
|
Anti-Infective Agents | 2 | 2016 | 983 | 0.040 |
Why?
|
Animals | 12 | 2022 | 168089 | 0.040 |
Why?
|
Mass Spectrometry | 2 | 2018 | 2189 | 0.040 |
Why?
|
Faculty, Medical | 1 | 2009 | 1205 | 0.040 |
Why?
|
Health Care Surveys | 3 | 2014 | 2425 | 0.040 |
Why?
|
Drug Utilization Review | 1 | 2001 | 248 | 0.040 |
Why?
|
Public Health | 2 | 2016 | 2672 | 0.040 |
Why?
|
Christianity | 1 | 2019 | 50 | 0.040 |
Why?
|
Zinc | 1 | 2024 | 672 | 0.040 |
Why?
|
Amenorrhea | 1 | 2023 | 483 | 0.040 |
Why?
|
Physical Examination | 1 | 2005 | 1255 | 0.040 |
Why?
|
Mental Health | 1 | 2014 | 3251 | 0.040 |
Why?
|
Transcription Factors | 1 | 2019 | 12101 | 0.040 |
Why?
|
Internet | 1 | 2011 | 3096 | 0.040 |
Why?
|
Reference Values | 3 | 2012 | 4921 | 0.040 |
Why?
|
Intention | 1 | 2022 | 347 | 0.040 |
Why?
|
Oceania | 1 | 2018 | 18 | 0.040 |
Why?
|
Health Surveys | 4 | 2011 | 4037 | 0.040 |
Why?
|
Superior Sagittal Sinus | 1 | 2018 | 15 | 0.040 |
Why?
|
Pituitary-Adrenal System | 1 | 2022 | 547 | 0.040 |
Why?
|
Urban Population | 2 | 2018 | 2036 | 0.040 |
Why?
|
Fatty Acids, Volatile | 1 | 2019 | 103 | 0.040 |
Why?
|
Nonprescription Drugs | 1 | 2020 | 118 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2013 | 14675 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2013 | 4321 | 0.040 |
Why?
|
ROC Curve | 2 | 2018 | 3584 | 0.040 |
Why?
|
Phosphates | 1 | 2022 | 763 | 0.040 |
Why?
|
Kidney | 2 | 2024 | 7033 | 0.040 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2022 | 695 | 0.040 |
Why?
|
Selection Bias | 1 | 2020 | 359 | 0.040 |
Why?
|
Puberty, Precocious | 1 | 2019 | 163 | 0.040 |
Why?
|
Iodide Peroxidase | 1 | 2019 | 294 | 0.040 |
Why?
|
Plasma | 1 | 2021 | 586 | 0.040 |
Why?
|
Puerperal Disorders | 1 | 2020 | 301 | 0.040 |
Why?
|
Aged | 9 | 2024 | 169292 | 0.040 |
Why?
|
Depressive Disorder | 1 | 2010 | 3727 | 0.040 |
Why?
|
Penicillin Resistance | 2 | 2009 | 75 | 0.040 |
Why?
|
Prognosis | 5 | 2019 | 29688 | 0.040 |
Why?
|
Aryldialkylphosphatase | 1 | 2017 | 64 | 0.030 |
Why?
|
Education, Medical | 1 | 2009 | 1725 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2018 | 413 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2020 | 633 | 0.030 |
Why?
|
Anemia | 1 | 2006 | 1504 | 0.030 |
Why?
|
Triglycerides | 2 | 2014 | 2457 | 0.030 |
Why?
|
Nitrogen Dioxide | 1 | 2019 | 521 | 0.030 |
Why?
|
Norway | 1 | 2017 | 499 | 0.030 |
Why?
|
Sex | 1 | 2016 | 53 | 0.030 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2022 | 1146 | 0.030 |
Why?
|
Disease Notification | 2 | 2006 | 95 | 0.030 |
Why?
|
Greece | 1 | 2017 | 340 | 0.030 |
Why?
|
DNA, Mitochondrial | 1 | 2021 | 865 | 0.030 |
Why?
|
South Australia | 1 | 2016 | 26 | 0.030 |
Why?
|
Suburban Population | 1 | 2016 | 54 | 0.030 |
Why?
|
Self Care | 2 | 2015 | 795 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2019 | 5250 | 0.030 |
Why?
|
Cognition Disorders | 1 | 2010 | 3976 | 0.030 |
Why?
|
Education, Medical, Continuing | 1 | 2001 | 825 | 0.030 |
Why?
|
Fructose | 1 | 2018 | 285 | 0.030 |
Why?
|
Data Interpretation, Statistical | 1 | 2005 | 2691 | 0.030 |
Why?
|
Pamphlets | 1 | 2015 | 71 | 0.030 |
Why?
|
Brazil | 1 | 2020 | 1228 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2008 | 12474 | 0.030 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2018 | 540 | 0.030 |
Why?
|
Antibody Specificity | 1 | 2017 | 1059 | 0.030 |
Why?
|
Longevity | 1 | 2023 | 1063 | 0.030 |
Why?
|
Prehypertension | 1 | 2015 | 63 | 0.030 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2017 | 361 | 0.030 |
Why?
|
Starch | 1 | 2015 | 79 | 0.030 |
Why?
|
New Zealand | 1 | 2016 | 358 | 0.030 |
Why?
|
Drug Administration Schedule | 2 | 2018 | 4851 | 0.030 |
Why?
|
Nitrogen Oxides | 1 | 2015 | 129 | 0.030 |
Why?
|
Marital Status | 1 | 2016 | 425 | 0.030 |
Why?
|
Serum Albumin | 1 | 2018 | 674 | 0.030 |
Why?
|
Area Under Curve | 1 | 2018 | 1636 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2018 | 982 | 0.030 |
Why?
|
C-Peptide | 1 | 2016 | 442 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 2021 | 1267 | 0.030 |
Why?
|
Leukocytes | 1 | 2022 | 2025 | 0.030 |
Why?
|
Emotions | 2 | 2017 | 2742 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 2 | 2012 | 1936 | 0.030 |
Why?
|
Drinking Behavior | 1 | 2014 | 103 | 0.030 |
Why?
|
Taste | 1 | 2015 | 189 | 0.030 |
Why?
|
Affective Symptoms | 1 | 2017 | 417 | 0.030 |
Why?
|
Family Practice | 2 | 2008 | 507 | 0.030 |
Why?
|
Pulse | 1 | 2014 | 218 | 0.030 |
Why?
|
Diet Records | 1 | 2015 | 427 | 0.030 |
Why?
|
Causality | 1 | 2020 | 1244 | 0.030 |
Why?
|
Faculty | 1 | 2017 | 383 | 0.030 |
Why?
|
Adolescent Nutritional Physiological Phenomena | 2 | 2005 | 62 | 0.030 |
Why?
|
Hospitals, Maternity | 1 | 2013 | 33 | 0.030 |
Why?
|
Perception | 1 | 2019 | 1198 | 0.030 |
Why?
|
Therapy, Computer-Assisted | 1 | 2015 | 265 | 0.030 |
Why?
|
Immunization | 1 | 2017 | 1218 | 0.030 |
Why?
|
Sodium Chloride, Dietary | 1 | 2015 | 292 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 2024 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2011 | 5333 | 0.030 |
Why?
|
Consumer Advocacy | 1 | 2013 | 83 | 0.030 |
Why?
|
Creatinine | 1 | 2018 | 1897 | 0.030 |
Why?
|
Growth and Development | 1 | 2012 | 46 | 0.020 |
Why?
|
Fetal Weight | 1 | 2012 | 87 | 0.020 |
Why?
|
Hospitalization | 1 | 2012 | 10707 | 0.020 |
Why?
|
Waist-Hip Ratio | 1 | 2013 | 518 | 0.020 |
Why?
|
Cities | 1 | 2014 | 541 | 0.020 |
Why?
|
Multilocus Sequence Typing | 1 | 2011 | 101 | 0.020 |
Why?
|
Hunger | 1 | 2013 | 205 | 0.020 |
Why?
|
Carbon Monoxide | 1 | 2015 | 547 | 0.020 |
Why?
|
Urban Health | 1 | 2014 | 532 | 0.020 |
Why?
|
Poverty | 1 | 2023 | 2691 | 0.020 |
Why?
|
Ozone | 1 | 2015 | 482 | 0.020 |
Why?
|
Finland | 1 | 2012 | 607 | 0.020 |
Why?
|
Diastole | 1 | 2014 | 782 | 0.020 |
Why?
|
Dietary Fiber | 1 | 2015 | 758 | 0.020 |
Why?
|
Psychological Tests | 1 | 2013 | 639 | 0.020 |
Why?
|
Hemoglobins | 2 | 2008 | 1525 | 0.020 |
Why?
|
Sex Characteristics | 2 | 2016 | 2640 | 0.020 |
Why?
|
Sexual Partners | 1 | 2016 | 800 | 0.020 |
Why?
|
Qualitative Research | 2 | 2014 | 3024 | 0.020 |
Why?
|
Bacterial Typing Techniques | 1 | 2011 | 262 | 0.020 |
Why?
|
Medicaid | 3 | 2012 | 2813 | 0.020 |
Why?
|
Sulfonamides | 1 | 2020 | 1977 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 2002 | 2527 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2019 | 3777 | 0.020 |
Why?
|
Genetic Loci | 1 | 2020 | 2623 | 0.020 |
Why?
|
Peptide YY | 1 | 2011 | 135 | 0.020 |
Why?
|
Information Storage and Retrieval | 1 | 2016 | 820 | 0.020 |
Why?
|
Geographic Information Systems | 1 | 2012 | 281 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2014 | 4340 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2012 | 6223 | 0.020 |
Why?
|
Methionine | 1 | 2012 | 570 | 0.020 |
Why?
|
Behavior Therapy | 1 | 2015 | 875 | 0.020 |
Why?
|
Operon | 1 | 2010 | 372 | 0.020 |
Why?
|
Social Behavior | 1 | 2016 | 1136 | 0.020 |
Why?
|
Ghrelin | 1 | 2011 | 251 | 0.020 |
Why?
|
Computers | 1 | 2011 | 591 | 0.020 |
Why?
|
Consumer Health Information | 1 | 2011 | 215 | 0.020 |
Why?
|
Biometry | 1 | 2012 | 563 | 0.020 |
Why?
|
Fasting | 1 | 2015 | 1603 | 0.020 |
Why?
|
Focus Groups | 1 | 2014 | 1413 | 0.020 |
Why?
|
Leg | 1 | 2014 | 1087 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 1743 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2016 | 1437 | 0.020 |
Why?
|
Mitochondria | 1 | 2021 | 3620 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2024 | 58952 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2014 | 1812 | 0.020 |
Why?
|
Insurance Claim Reporting | 1 | 2008 | 165 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15841 | 0.020 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2010 | 550 | 0.020 |
Why?
|
Rural Population | 1 | 2018 | 2277 | 0.020 |
Why?
|
Erythrocyte Indices | 1 | 2008 | 144 | 0.020 |
Why?
|
Nasal Cavity | 1 | 2009 | 304 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2013 | 915 | 0.020 |
Why?
|
Physicians | 1 | 2005 | 4584 | 0.020 |
Why?
|
Acids | 1 | 2007 | 124 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2610 | 0.020 |
Why?
|
Minority Groups | 1 | 2014 | 1201 | 0.020 |
Why?
|
Antigens, Dermatophagoides | 1 | 2006 | 98 | 0.020 |
Why?
|
Cockroaches | 1 | 2006 | 97 | 0.020 |
Why?
|
Group Practice | 1 | 2007 | 151 | 0.020 |
Why?
|
Academic Medical Centers | 2 | 2006 | 2756 | 0.020 |
Why?
|
Nose | 1 | 2010 | 521 | 0.020 |
Why?
|
DNA | 1 | 2020 | 7189 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2017 | 2569 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2017 | 3596 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2008 | 1624 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10756 | 0.020 |
Why?
|
Counseling | 1 | 2013 | 1536 | 0.020 |
Why?
|
Head | 1 | 2011 | 922 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2013 | 2697 | 0.020 |
Why?
|
Cholesterol | 1 | 2014 | 2902 | 0.020 |
Why?
|
Insect Proteins | 1 | 2006 | 254 | 0.020 |
Why?
|
Acute Disease | 2 | 2006 | 7226 | 0.020 |
Why?
|
DNA, Bacterial | 1 | 2010 | 1470 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2015 | 2004 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9417 | 0.020 |
Why?
|
Age of Onset | 1 | 2012 | 3307 | 0.010 |
Why?
|
Social Marketing | 1 | 2004 | 52 | 0.010 |
Why?
|
Interleukin-13 | 1 | 2006 | 392 | 0.010 |
Why?
|
Family Health | 1 | 2009 | 1254 | 0.010 |
Why?
|
Persuasive Communication | 1 | 2004 | 58 | 0.010 |
Why?
|
Bacterial Infections | 1 | 2012 | 1390 | 0.010 |
Why?
|
Cysteine Endopeptidases | 1 | 2006 | 551 | 0.010 |
Why?
|
Monte Carlo Method | 1 | 2009 | 1256 | 0.010 |
Why?
|
Sampling Studies | 1 | 2005 | 615 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8519 | 0.010 |
Why?
|
Memory | 1 | 2013 | 2190 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2022 | 15920 | 0.010 |
Why?
|
Embryonic and Fetal Development | 1 | 2003 | 420 | 0.010 |
Why?
|
Culture | 1 | 2005 | 623 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2006 | 1176 | 0.010 |
Why?
|
Penicillins | 1 | 2004 | 403 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2016 | 64681 | 0.010 |
Why?
|
Washington | 1 | 2001 | 314 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2022 | 17897 | 0.010 |
Why?
|
Personal Satisfaction | 1 | 2005 | 645 | 0.010 |
Why?
|
Insurance Coverage | 1 | 2012 | 1935 | 0.010 |
Why?
|
Pilot Projects | 1 | 2014 | 8642 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2014 | 12341 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2006 | 1838 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2002 | 13632 | 0.010 |
Why?
|
Iron | 1 | 2008 | 1791 | 0.010 |
Why?
|
Demography | 1 | 2004 | 1641 | 0.010 |
Why?
|
Drug Resistance | 1 | 2005 | 1594 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13511 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2006 | 3155 | 0.010 |
Why?
|
Forecasting | 1 | 2007 | 2928 | 0.010 |
Why?
|
SEER Program | 1 | 2002 | 1453 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2006 | 2420 | 0.010 |
Why?
|
Patient-Centered Care | 1 | 2006 | 1427 | 0.010 |
Why?
|
Administration, Oral | 1 | 2004 | 4015 | 0.010 |
Why?
|
Data Collection | 1 | 2005 | 3320 | 0.010 |
Why?
|
Recurrence | 1 | 2008 | 8457 | 0.010 |
Why?
|
Students, Medical | 1 | 2009 | 1940 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2002 | 3512 | 0.010 |
Why?
|
Heart Rate | 1 | 2004 | 4197 | 0.010 |
Why?
|
Decision Making | 1 | 2005 | 3931 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2005 | 3885 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2005 | 3200 | 0.010 |
Why?
|
Insurance, Health | 1 | 2003 | 2493 | 0.010 |
Why?
|
Models, Biological | 1 | 2004 | 9458 | 0.000 |
Why?
|
Medicare | 1 | 2002 | 6774 | 0.000 |
Why?
|